Industry Focus

Here's why Roche's acquisition of gene therapy pioneer Spark Therapeutics and Biogen's acquisition of gene therapy upstart Nightstar Therapeutics could put Regenxbio in play. RHHBY, ONCE, BIIB, NITE, RGNX

Check out more of our content here:

Direct download: 20190306_IF_healthcare.mp3
Category:general -- posted at: 3:30pm EDT

1